MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2024 International Congress

    ATP8A2 Mutation in a Tunisian Family : Expanding The Clinical Spectrum

    M. Ben Hafsa, H. Benrhouma, T. Ben Younes, R. Maroofian, H. Klaa, H. Houlden, I. Kraoua (Tunis, Tunisia)

    Objective: Our aim was to report the clinical and paraclinical findings from two siblings who presented with a new phenotype of ATP8A2 gene mutation. Background:…
  • 2024 International Congress

    Rare Variant Burden is Increased in Sporadic Late-onset Chinese Parkinson’s Disease Patients

    RWH. Ho, ZW. Xiong, RCN. Lo, HF. Liu, PWL. Ho, SL. Ho, SYY. Pang (Hong Kong, Hong Kong)

    Objective: We aim to study the rare variant burden in a panel of 29 Parkinson’s disease (PD) candidate genes (Table 1) in a cohort of…
  • 2024 International Congress

    Expanding the Spectrum of Autosomal Recessive Genes Responsible for Parkinson’s Disease in the Chinese Population

    Y. Zhao, H. Pan, J. Guo, Z. Liu, B. Tang (Changsha, China)

    Objective: We aimed to identify novel candidate autosomal recessive (AR) genes combining whole-exome sequencing (WES) and long-read sequencing data (LRS) in autosomal recessive Parkinson’s disease (AR-PD) families and sporadic early-onset…
  • 2024 International Congress

    Relationship Between Non-Motor Symptoms, Kinematic Features, and Quality of Life in Cervical Dystonia

    T. Hart, L. Heideman, D. Martino, M. Beudel, A. Sadnicka, F. Morgante (London, United Kingdom)

    Objective: To assess the extent of non-motor symptoms (NMS) in Cervical Dystonia (CD) and investigate the interaction between NMS, kinematic metrics of motor severity, and…
  • 2024 International Congress

    Brain De-Ironization with Nasal Spray of Iron Chelator in Treatment of Multiple System Atrophy, a Case Trial

    A. Amoushahi, A. Sahebkar, P. Moeini, N. Chitsaz (Isfahan, Islamic Republic of Iran)

    Objective: Iron removal seems to be a treatment approach in Multiple system atrophy (MSA) because pathological findings shows the accumulation of iron and α-synuclein protein…
  • 2024 International Congress

    PD GENEration: a genetic analysis beyond the classical 7 Parkinson’s disease genes

    I. Keller Sarmiento, V. Pitz, C. Blauwendraat, Z. Fang, T. Tatiana Foroud, A. Hall, K. Marder, I. Mata, M. Nance, M. Schwarzchild, T. Simuni, A. Wills, S. Lawrence, K. Ghosh Galvelis, J. Beck, A. Naito, R. Alcalay, N. Mencacci (Chicago, USA)

    Objective: To expand the analysis of whole-exome sequencing (WES) data from patients with Parkinson’s Disease (PD) from the PD GENEration cohort. We looked for variants…
  • 2024 International Congress

    Validation of Inertial Measurement Units and an application compared with the reference system to assess the gait in hereditary spastic paraplegia

    D. Cubillos-Arcila, A. Ivaniski-Mello, E. de Borba, L. Peyré-Tartaruga, J. Morales Saute (Porto Alegre, Brazil)

    Objective: To assess the reliability of spatiotemporal parameter measurements in HSP patients obtained from an inertial system and an application compared with the conventional motion…
  • 2024 International Congress

    Disease Burden and Treatment in Patients With Essential Tremor in the United States: Real-World Evidence From a Cross-Sectional Survey of Physicians and Patients

    J. Williams, A. Gillespie, L. Harrison, S. Thomas, A. Sillah, L. Barbato, J. Lin, S. Shah (Bakersfield, USA)

    Objective: To characterize disease burden and medication treatment insights in patients with essential tremor (ET) using Adelphi Essential Tremor Disease Specific Programme (DSP)TM data. Background:…
  • 2024 International Congress

    Ataxic-spastic gait: a form of presentation of DYT5/DYT-GCH1

    V. Mendes Ferreira, M. Magriço, B. Meira, P. Bugalho (Lisboa, Portugal)

    Objective: Describe a case of DYT5/DYT-GCH1 presenting with an ataxic-spastic gait Background: DYT5/DYT-GCH1 is an autosomal dominant disease typically characterized by lower limb dystonia starting…
  • 2024 International Congress

    Frequency of LRRK2 p.L1795F variant in Parkinson’s Disease patients from Central Europe within the CEGEMOD consortium

    M. Ostrozovicova, G. Tamas, K. Soos, P. Dusek, M. Grofik, V. Han, P. Holly, R. Jech, P. Klivenyi, N. Kovacs, K. Kulcsarova, E. Kurca, A. Lackova, J. Necpal, D. Pinter, E. Ruzicka, T. Serranova, K. Smilowska, I. Straka, T. Svorenova, P. Valkovic, K. Zarubova, H. Houlden, M. Rizig, M. Skorvanek (Kosice, Slovakia)

    Objective: The aim of this study was to investigate the presence of LRRK2 p.L1795F variant in PD patients from Central Europe. Background: Pathogenic variants in…
  • « Previous Page
  • 1
  • …
  • 176
  • 177
  • 178
  • 179
  • 180
  • …
  • 1554
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • #25179 (not found)
  • Screening and Treatment of Depression in Parkinson’s Disease within Movement Disorders Centers: A Quality Improvement Initiative
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • An atypical and interesting feature of Parkinson´s disease
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • DaTscan in clinical evaluation of Multiple System Atrophy
  • Decision-making process for opicapone’s bedtime regimen
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley